ADMA director buys 12,500 shares at $8.01
ADMA Biologics director Jerrold B. Grossman bought additional shares of company stock.
Rhea-AI Filing Summary
ADMA Biologics director Jerrold B. Grossman bought additional shares of company stock. On May 12, 2026, he made an open-market purchase of 12,500 shares of ADMA common stock at $8.01 per share. Following this transaction, he directly holds 513,884 common shares, which includes 10,690 RSUs granted on February 9, 2026 that vest in two equal installments on August 9, 2026 and February 9, 2027, along with 503,194 owned shares. He also has several indirect holdings: 175 shares through Brookwood LLC, 38,294 shares through the Jerrold Grossman 2019 Irrevocable Trust, 31,381 shares held by Genesis Foundation Inc., and 22,857 shares owned by his wife.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 12,500 shares
Net Buy
5 txns
Insider
Grossman Jerrold B
Role
Director
Bought
12,500 shs ($100K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 12,500 | $8.01 | $100K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 513,884 shares (Direct);
Common Stock — 92,707 shares (Indirect, See footnote)
Footnotes (6)
- F1. Represents an open market purchase in a single transaction.
- F2. Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, half of which will vest on August 9, 2026, and the other half of which will vest on February 9, 2027, subject to the Reporting Person's continued service as of each such vesting date; and (ii) 503,194 shares of common stock owned by the Reporting Person.
- F3. These shares are owned by Brookwood LLC ("Brookwood"). The Reporting Person is the managing member of Brookwood.
- F4. These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
- F5. These shares are owned by Genesis Foundation Inc. ("Genesis"). The Reporting Person is the President of Genesis.
- F6. These shares are owned by the Reporting Person's wife.
Key Figures
Shares purchased: 12,500 shares
Purchase price: $8.01 per share
Direct holdings post-transaction: 513,884 shares
+5 more
8 metrics
Shares purchased
12,500 shares
Open-market buy on May 12, 2026
Purchase price
<money>$8.01</money> per share
Open-market transaction
Direct holdings post-transaction
513,884 shares
Common stock directly held after purchase
RSUs granted
10,690 RSUs
Granted February 9, 2026, vesting in two tranches
Common shares within direct total
503,194 shares
Owned common stock as of transaction date
Brookwood LLC holdings
175 shares
Indirect ownership via Brookwood LLC
2019 Irrevocable Trust holdings
38,294 shares
Jerrold Grossman 2019 Irrevocable Trust
Genesis Foundation holdings
31,381 shares
Held by Genesis Foundation Inc.
Key Terms
open market purchase, RSUs, irrevocable trust, indirect ownership, +1 more
5 terms
open market purchase financial
"Represents an open market purchase in a single transaction."
An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.
RSUs financial
"Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026,"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
irrevocable trust financial
"These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust,"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
indirect ownership financial
"direct_or_indirect: "I", nature_of_ownership: "See footnote""
restricted stock units financial
"10,690 RSUs granted on February 9, 2026, half of which will vest"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ADMA (ADMA) director Jerrold Grossman do in this Form 4 filing?
Director Jerrold B. Grossman reported buying 12,500 shares of ADMA common stock in an open-market transaction. The filing also updates his total direct and indirect holdings, including RSUs, trusts, an LLC, a foundation, and shares owned by his wife.
What are Jerrold Grossman’s direct ADMA (ADMA) holdings after this transaction?
After the transaction, Grossman directly holds 513,884 ADMA common shares. This total includes 10,690 restricted stock units granted February 9, 2026, and 503,194 shares of common stock that he already owned as of the transaction date.
What RSUs does Jerrold Grossman hold in ADMA (ADMA) and when do they vest?
Grossman holds 10,690 ADMA restricted stock units granted February 9, 2026. Half are scheduled to vest on August 9, 2026, and the remaining half on February 9, 2027, contingent on his continued service with the company through those vesting dates.
Is the ADMA (ADMA) transaction described as an open-market purchase?
Yes. A footnote states the 12,500-share transaction is an open-market purchase in a single trade. This means Grossman bought shares directly on the market rather than through an option exercise or other derivative-related transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
